Bioplus Specialty Pharmacy Ca, LLC

Bioplus Specialty Pharmacy Ca, LLC was paid $8.88M by Medicaid between Jan 2018 and Nov 2024, across 22 billing codes. Its largest line is B4105, In-line cartridge containing digestive enzyme(s) for enteral feeding, each — 71% of everything it billed.

33Billing provider infoBIOPLUS SPECIALTY PHARMACY CA, LLC
GARDEN GROVE, CA 92841

33aNPI1013913458assigned 06/21/2005

33bProvider typeDurable Medical Equipment & Medical Supplies

28Total paid$8.88M

24GClaims78,415

24DCodes billed22

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in California

Rank by total paid#41 of 946

Median peer was paid$15K

This provider vs. median582×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	18,740	$502K
2019	20,419	$1.10M
2020	18,784	$1.51M
2021	12,129	$1.83M
2022	4,613	$586K
2023	2,307	$1.58M
2024incomplete	1,423	$1.77M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
B4105	In-line cartridge containing digestive enzyme(s) for enteral feeding, each	71%	977	918	$6.29M
Z5999		8.3%	5,582	4,771	$739K
J7639	Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	6.3%	1,080	827	$557K
J7131	Hypertonic saline solution, 1 ml	6.2%	11,120	10,471	$547K
J7507	Tacrolimus, immediate release, oral, 1 mg	1.9%	13,144	10,644	$170K
J7517	Mycophenolate mofetil, oral, 250 mg	1.5%	7,572	6,884	$130K
J7518	Mycophenolic acid, oral, 180 mg	1.4%	2,292	2,093	$123K
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	<1%	977	651	$79K
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	<1%	11,799	11,344	$61K
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	<1%	12,699	10,822	$59K
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	<1%	807	780	$55K
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	<1%	1,613	955	$36K

10 more codes

J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	6,541	$20K
A4209	Syringe with needle, sterile 5 cc or greater, each	<1%	395	$4K
J7520	Sirolimus, oral, 1 mg	<1%	59	$4K
A4208	Syringe with needle, sterile 3 cc, each	<1%	884	$4K
A4215	Needle, sterile, any size, each	<1%	40	$2K
A7013	Filter, disposable, used with aerosol compressor or ultrasonic generator	<1%	161	$1K
A7015	Aerosol mask, used with dme nebulizer	<1%	553	$1K
J7515	Cyclosporine, oral, 25 mg	<1%	29	$474.26
A4206	Syringe with needle, sterile, 1 cc or less, each	<1%	47	$61.87
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	44	$44.33

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHEEHAN, ASHLEY (CREDENTIALING SPECIALIST)

Same official

Other billing entities under SHEEHAN, ASHLEY

Full network →

Provider	Location	Paid
Bioplus Specialty Pharmacy, INC.	Lake Mary, FL	$317K
Bioplus Specialty Infusion Al, LLC	Dothan, AL	$88K
Bioplus Specialty Infusion Ca, LLC	Torrance, CA	$27K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.